Effects of Mfn2 Gene Overexpression on EGFR Expression and Angiogenesis of a Heterologous Graft Model for Human Breast Infiltrating Duct Carcinoma in Nude Mice

No abstract is available for this paper.

• Publication year

  2015

• Venue

  Journal of cancer prevention

• Publication date

  2015-12-02

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.12691/AJCP-3-6-3
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Anti‐Compression and Anti‐Angiogenic Therapy for Breast Cancer

  2015cited by this paper
• Anti-vascular endothelial growth factor therapy in breast cancer: game over?

  2015cited by this paper
• Tailoring therapies—improving the management of early breast cancer: St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2015

  2015cited by this paper
• Adjuvant bisphosphonate treatment in early breast cancer: meta-analyses of individual patient data from randomised trials.

  2015cited by this paper
• Calcium Homeostasis and Organelle Function in the Pathogenesis of Obesity and Diabetes.

  2015cited by this paper
• A cohort study of MFN2 mutations and phenotypic spectrums in Charcot–Marie–Tooth disease 2A patients

  2015influential reference
• Benefit to neoadjuvant anti-human epidermal growth factor receptor 2 (HER2)-targeted therapies in HER2-positive primary breast cancer is independent of phosphatase and tensin homolog deleted from chromosome 10 (PTEN) status.

  2015cited by this paper
• PI3K inhibition results in enhanced estrogen receptor function and dependence in hormone receptor–positive breast cancer

  2015cited by this paper
• Early onset Charcot‐Marie‐Tooth neuropathy type 2A and severe developmental delay: expanding the clinical phenotype of MFN2‐related neuropathy

  2015cited by this paper
• Lentivirus vector-mediated mitofusin-2 overexpression in rat ovary changes endocrine function and promotes follicular development in vivo

  2014cited by this paper
• Anti-Tumor Effects of Mfn2 in Gastric Cancer

  2013cited by this paper
• Pro-apoptotic and anti-proliferative effects of mitofusin-2 via Bax signaling in hepatocellular carcinoma cells

  2012cited by this paper
• The promoter activity of human Mfn2 depends on Sp1 in vascular smooth muscle cells.

  2012cited by this paper
• Anti-tumour efficacy of mitofusin-2 in urinary bladder carcinoma

  2011cited by this paper
• HSG provides antitumor efficacy on hepatocellular carcinoma both in vitro and in vivo.

  2010cited by this paper
• Molecular Machinery of Mitochondrial Fusion and Fission*

  2008cited by this paper
• Adenovirus-expressed human hyperplasia suppressor gene induces apoptosis in cancer cells

  2008cited by this paper
• Mitofusin 2: A Mitochondria-Shaping Protein with Signaling Roles Beyond Fusion

  2008cited by this paper
• Mitofusin 2 tethers endoplasmic reticulum to mitochondria

  2008cited by this paper
• The Role of VEGF and EGFR Inhibition: Implications for Combining Anti–VEGF and Anti–EGFR Agents

  2007cited by this paper
• Altered Axonal Mitochondrial Transport in the Pathogenesis of Charcot-Marie-Tooth Disease from Mitofusin 2 Mutations

  2007cited by this paper
• ERBB Receptors and Cancer: The Complexity of Targeted Inhibitors

  2005cited by this paper
• Epidermal growth factor receptor in tumor angiogenesis.

  2004cited by this paper
• Late Breaking Science Abstracts

  2004cited by this paper
• Dysregulation of HSG triggers vascular proliferative disorders

  2004cited by this paper
• Overview of epidermal growth factor receptor biology and its role as a therapeutic target in human neoplasia.

  2002cited by this paper
• Differential regulation of tumor angiogenesis by distinct ErbB homo- and heterodimers.

  2002cited by this paper
• Control of mitochondrial morphology by a human mitofusin.

  2001cited by this paper
• Neutralizing antibodies against epidermal growth factor and ErbB-2/neu receptor tyrosine kinases down-regulate vascular endothelial growth factor production by tumor cells in vitro and in vivo: angiogenic implications for signal transduction therapy of solid tumors.

  1997cited by this paper

• No citing papers are available for this paper.